Spina bifida is a congenital condition that usually occurs as a result of mutation in the spinal cord. The condition is more prevalent among Hispanics and Caucasians, and women are more affected than men. It can happen at any position along the spinal cord in case neural tube does not close properly. This causes defect in the formation and closure of backbone which protects the spinal cord. It often leads to damage of spinal cord and nerves related to it.
Technological advancements is a major factor boosting the growth of the global spina bifida market. Key players in the market are focusing on development of more innovative technologies for the treatment of spina bifida, as awareness about the disorder is increasing. Factors such as rise in awareness, increase in incidence of spina bifida and associated complications, neglected therapeutic needs, favorable regulatory guidelines, surge in adoption rate, expanding government assistance, rise in per capita income, and improved reimbursement policies boost the growth of the global spina bifida market. However, high cost of treatment, complications of medical procedures, and poor health care services in developing countries are anticipated to restrain the global market.
The global spina bifida market can be segmented based on type of spina bifida disorder, diagnosis, treatment, and end-user. In terms of type of disorder, the global market can be classified into meningocele, occulta, myelomeningocele, and closed neural tube defects. Based on diagnosis, the global spina bifida market can be categorized into blood tests, amniocentesis, ultrasound, and others. The blood tests segment can be divided into maternal serum alpha-fetoprotein (MSAFP) test, test performed to confirm high AFP levels, and other blood tests. In terms of treatment, the global spina bifida market can be classified into medicines, medical procedures, surgeries, and others. The medical procedures segment can be categorized into urinary diversion, urinary catheterization, and enema. The surgeries segment can be divided into caesarean section, surgery of the spine, fetal endoscopic surgery, suprapubic cystostomy, and spinal fusion. The medicines segment can be bifurcated into antibiotics and others. Based on end-user, the spina bifida market can be segmented into hospitals, drugstores, pharmacies, clinics, diagnostic centers, and others.
In terms of region, the global spina bifida market can be segmented into North America, Europe, Asia, Latin America, and Rest of the World. North America and Europe accounted for significant shares of the global market in 2017, followed by Asia Pacific. The U.S. dominated the market in North America due to strong research & development, technological advancements, and rise in awareness about the treatment and management of congenital diseases. Government support toward research & development expenditure and well-developed reimbursement policies are projected to drive the spina bifida market in Europe. The spina bifida market in Asia Pacific is anticipated to witness the fastest growth during the forecast period. Launch of new products, advancing health care technologies, favorable regulations, and rise in awareness are likely to drive the spina bifida market in the region from 2018 to 2026.
Key players operating in the global spina bifida market are B. Braun Melsungen AG, Boston Scientific, C. R. Bard, Inc., C. B. Fleet, Cook Medical, Covidien Private Ltd., Ethicon, Fujifilm, KARL STORZ, Medline Industries, Olympus Corporation, Pacific Hospital Supply Co., Ltd., Medtronic plc, Smith & Nephew, Teleflex Incorporation, Stryker, and ConvaTec Group plc, among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.